Semaglutides ability to regulate appetite and slow digestion helps maintain weight loss over time
Instrumental Variables Regression with Weak Instruments
10.1002/jmor.1052130305 85
Source : NEJM SURMOUNT-1 Trial Over 90% achieved 5%+ weight loss 9 out of 10 participants lost at least 5% of their body weight using GLP-1 + GIP a powerful early milestone toward long-term success
Patients throughout Boise and the Treasure Valley choose us because: We offer medically supervised programs Treatments are customized, not cookie-cutter We focus on long-term metabolic health We prioritize safety and clinical oversight Whether your goal is fat loss, improved energy, or overall metabolic support, we build a strategy around your body
If you develop vertigo or other side effects, your provider can adjust your dose, extend your dose-escalation timeline, or recommend lifestyle modifications